PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.10 (1.04%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.65
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Commencement of Trading OTCQB Venture Mkt in USA

1 Feb 2021 07:00

RNS Number : 4226N
Tekcapital plc
01 February 2021
 

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

1st February 2021

 

("Tekcapital", the "Company" or "the Group")

 

Tekcapital commences trading on the OTCQB Venture Market in the United States

 

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating marketplace value from investing in university technology, is pleased to announce that the Company's shares will cross trade publicly on the US OTCQB Venture Market ("OTCQB"), under the ticker TEKCF, commencing 1st February 2021.

 

Tekcapital's ordinary shares will continue to trade on the AIM Market of the London Stock Exchange under the ticker TEK and are fully fungible. Tekcapital is not conducting a fundraising associated with this initiation of a quotation and cross-trading on the OTCQB Market. The Group will continue to rely on the announcements and disclosures it makes to the London Stock Exchange and has no Sarbanes-Oxley or SEC reporting requirements.

 

The cross-trading facility is provided through OTC Markets Group Inc., located in New York. OTC Markets operates the world's largest electronic interdealer quotation system for US broker dealers and offers multiple media channels to increase the visibility of OTC-listed companies.

 

Jonathan Dickson, VP of International Corporate Services at OTC Markets, said: "We are delighted to welcome Tekcapital plc to the OTCQB Market. With its primary listing remaining on London's AIM, the OTCQB Market's cross trading facility will allow Tekcapital to provide investors in the United States with the ability to access the Company's Ordinary Shares in U.S. dollars and during U.S. market hours. The OTCQB Market supports international companies seeking to strengthen visibility and transparency within the U.S. public market. Trading on AIM and on the OTCQB Market will enable Tekcapital to efficiently build global investor awareness and provide U.S. investors with a seamless trading facility, enabling investors to more easily trade through the broker of their choice. We would like to wish Tekcapital every success in their future trading on the OTCQB Market."

 

Dr. Clifford M. Gross, Tekcapital CEO, commented, "Tekcapital's portfolio companies are rapidly building a presence in the U.S. and as such we are delighted to be joining the OTCQB Market, with a view towards increasing our visibility to the investment community and broadening our shareholder base."

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed intellectual properties (IP) and provides a range of IP investment services to make it easy for organisations to commercialise university-developed technology. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com

LEI: 213800GOJTOV19FIFZ85

For further information, please contact:

 

Tekcapital Plc 

 

Via Flagstaff IR

Clifford M. Gross, Ph.D. 

 

 

 

 

 

SP Angel Corporate Finance LLP (Nominated Adviser and Joint Broker)

 

+44 (0) 20 3470 0470 

Richard Morrison / Charlie Bouverat (Corporate Finance)

Abigail Wayne (Corporate Broking)

 

 

 

Flagstaff Strategic and Investor Communications +44 (0)207 129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

 

OTC Markets

Jonathan Dickson

 

 

+44 (0) 20 4526 4581

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, on social media, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Forward-looking statements express, as at the date of this release, the Company's plans, estimates, valuations, forecasts, projections, opinions, expectations or beliefs as to future events, results or performance. Forward-looking statements involve a number of risks and uncertainties, many of which are beyond the Company's control, including those associated with COVID-19, and there can be no assurance that such statements will prove to be accurate. No assurance is given that such forward looking statements or views are correct or that the objectives of the Company will be achieved. Further, valuations of Company's portfolio investments and net asset value can and will fluctuate over time due to a variety of factors and this could have a material impact on the Company's financial performance. Tekcapital neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which may differ from those anticipated.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKCBBPBKDNDB
Date   Source Headline
8th Mar 20217:00 amRNSBelluscura FDA Clearance
5th Feb 20217:00 amRNSSalarius Update
4th Feb 20212:05 pmRNSSecond Price Monitoring Extn
4th Feb 20212:00 pmRNSPrice Monitoring Extension
2nd Feb 20212:47 pmRNSNotification of Major Shareholding
1st Feb 202111:05 amRNSSecond Price Monitoring Extn
1st Feb 202111:00 amRNSPrice Monitoring Extension
1st Feb 20219:05 amRNSSecond Price Monitoring Extn
1st Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20217:00 amRNSCommencement of Trading OTCQB Venture Mkt in USA
12th Jan 20212:05 pmRNSSecond Price Monitoring Extn
12th Jan 20212:00 pmRNSPrice Monitoring Extension
6th Jan 20217:00 amRNSLucyd -Crowdfunding and launch Lyte E glasses
21st Dec 202012:35 pmRNSHolding(s) in Company
7th Dec 20202:49 pmRNSNotification of Major Holdings
3rd Dec 20203:46 pmRNSNotification of Major Holdings
3rd Dec 20209:05 amRNSSecond Price Monitoring Extn
3rd Dec 20209:00 amRNSPrice Monitoring Extension
3rd Dec 20207:00 amRNSBelluscura Update
2nd Dec 20209:00 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSSalarius launches on Amazon North America
1st Dec 20203:19 pmRNSTotal Voting Rights
18th Nov 20202:05 pmRNSSecond Price Monitoring Extn
18th Nov 20202:00 pmRNSPrice Monitoring Extension
17th Nov 20204:56 pmRNSNotification of Major Holdings
17th Nov 20207:00 amRNSPlacing to Raise £380,000
30th Oct 20206:08 pmRNSTotal Voting Rights
28th Oct 20207:00 amRNSLucyd Patents
5th Oct 20207:00 amRNSPortfolio Company Update: Guident Ltd
1st Oct 202010:18 amRNSExercise of Stock Options and Total Voting Rights
28th Sep 20207:00 amRNSLucyd Ecommerce management appointment
24th Sep 20207:00 amRNSSalarius Mexican Distribution Agreement
21st Sep 20207:00 amRNSGuident Files Additional Patent
16th Sep 20207:00 amRNSSalarius distribution agreement
14th Sep 20207:00 amRNSGuident Update
7th Sep 20207:00 amRNSGuident Update
27th Aug 20201:44 pmRNSGrant of Stock Options
21st Aug 20207:00 amRNSUnaudited Half-Yearly Report
27th Jul 202012:49 pmRNSResults of Annual General Mtg & Directorate Change
27th Jul 20207:00 amRNSNotice of Investor and Analyst Conference Call
22nd Jul 20207:00 amRNSLucyd Update
13th Jul 20207:00 amRNSInvestor and Analyst Conference Call
7th Jul 20201:16 pmRNSNotification of Major Holdings
30th Jun 20204:43 pmRNSNotice of AGM
17th Jun 20202:52 pmRNSNotification of Major Holdings
17th Jun 20207:30 amRNSPortfolio Company Update: Belluscura plc
16th Jun 20207:00 amRNSGuident Update
29th May 20203:18 pmRNSPosting of Annual Report & Total Voting Rights
22nd May 20201:25 pmRNSNotification of Major Shareholdings
22nd May 20207:00 amRNSGuident Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.